Humana

There will be plenty more quarterly reports this week for analysts and traders to peruse. On the schedule are Coca-Cola (NYSE: KO), Hasbro (NASDAQ: HAS), PepsiCo (NYSE: PEP), Time Warner (NYSE: TWX), Visa (NYSE: V), Walt Disney (NYSE: DIS), Whole Foods Market (NASDAQ: WFM) and Yum! Brands (NYSE:...

According to a recent CNN article, approximately 2.5 million more young adults in the United States are now receiving health coverage as a part of President Obama's healthcare reform, the Patient Protection and Affordable Care Act. A part of the reform that became effective in September allows...

Halloween and the Day of the Dead arrive this week. If analysts' forecasts are correct, there are only a few earnings reports that may scare investors. For instance, Alpha Natural Resources (NYSE: ANR) earnings are predicted to have fallen 93.1% year over year to $0.58 per share. Allstate (NYSE:...

Goldman Sachs has published a report upgrading Humana (NYSE: HUM) from Neutral to Buy. In the report, Goldman Sachs wrote, "We think fiscal pressures will drive a bigger role for Medicare Advantage (MA) and ultimately a phasing-out of unmanaged ‘traditional' Medicare. Even without policy changes,...

Quarterly reports of note scheduled for this week include those from Archer Daniels Midland (NYSE: ADM), General Motors (NYSE: GM), MasterCard (NYSE: MA), Procter & Gamble (NYSE: PG) and Time Warner (NYSE: TWX), all of which are expected to post earnings growth, as well as Pfizer (NYSE: PFE)...

PowerShares S&P SmallCap Health Care (NYSE: PSCH) is up nearly 22% year to date. The investment seeks to replicate the S&P SmallCap 600 Capped Health Care index, which is comprised of common stocks of U.S. health care companies. Top holdings include Regeneron Pharmaceuticals (NASDAQ: REGN...

Credit Suisse has made a number of updated in a research report published today. Research In Motion Limited (NASDAQ: RIMM) had its rating downgraded from Outperform to Neutral. At the same time, credit Suisse lowered its price target on the company's stock from $70 to $30. In the report, Credit...

StifeL Nicolaus has raised the price targets on the following companies: Crocs (NASDAQ: CROX) from $26 to $28, Buy Hansen Natural Corporation (NASDAQ: HANS) from $71 to $78, Buy Humana (NYSE: HUM) from $79 to $90, Buy

Citadel Securities has changed the price target on the following companies: Aetna Inc (NYSE: AET) / $44.39, Neutral Price Target $49.00 Previous Price Target: $40.00 Amerigroup Corporation (NYSE: AGP) / $67.88, Neutral Price Target $60.00 Previous Price Target: $43.00 Humana Inc (NYSE: HUM) / $...

Jefferies & Company has raised the price target on Humana (NYSE: HUM) from $82 to $90 and maintains its Buy rating.

Goldman Sachs has increased Price Targets for most managed care names, including WellCare and Humana. In the report Goldman Sachs writes, "We have increased our price targets across most managed care names as we incorporate explicit “per member”-derived M&A values for a potential resumption of...

Jefferies has upgraded Humana (NYSE: HUM) from Hold to Buy and has raised the price target from $65 to $74.

JP Morgan raises the Price Target to $63 from $61 after Humana (NYSE: HUM) posted Q4 EPS of “$0.63 vs our/consensus $0.69/0.78.” The report notes, “much like others this season so far, the report benefited from moderate med utilization offset by a heavy dose of cleanup/one-time items (about $1/...

JP Morgan has raised the price target on Humana, Inc. (NYSE: HUM) from $61 to $63 and maintains its Neutral rating.

Credit Suisse is out with its report today on Humana (NYSE: HUM), raising its PT from $70 to $71. In a note to clients, Credit Suisse writes, "HUM 2011 guidance increased to $5.95 - $6.15, ex-charge 25c to exit TRICARE ($5.70-$5.90 GAAP), reflecting better than expected MA and stand-alone Part D...